Crinetics Pharmaceuticals, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $4.70M, a 3.71% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $9.94M, a 123.32% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $18.97M, a 97.49% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $7.45M, a 28.17% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $35.40M, a 12.51% decline from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $40.46M, a 101.40% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $20.09M, a 325.57% increase from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $4.72M, a 50.49% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $4.70M 10-Q · filed 2026-08-03 | $41.06M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $9.94M 10-Q · filed 2026-05-07 | $40.89M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $18.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $35.40M 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.45M 10-Q · filed 2025-11-06 | $26.04M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $4.53M 10-Q · filed 2026-08-03 | $28.96M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $4.45M 10-Q · filed 2026-05-07 | $33.67M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $9.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $40.46M 10-K · filed 2026-02-26 |
| 2024-09-30 | $10.37M 10-Q · filed 2025-11-06 | $38.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $9.24M 10-Q · filed 2025-08-07 | $38.74M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $11.24M 10-Q · filed 2025-05-08 | $30.85M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $7.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $20.09M 10-K · filed 2026-02-26 |
| 2023-09-30 | $10.70M 10-Q · filed 2024-11-12 | $12.65M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.35M 10-Q · filed 2024-08-08 | $3.04M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $484.00K 10-Q · filed 2024-05-09 | $3.42M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.72M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.09M 10-Q · filed 2023-11-07 | $6.45M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.74M 10-Q · filed 2023-08-08 | $5.85M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.78M 10-Q · filed 2023-05-09 | $4.86M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.14M 10-K · filed 2024-02-28 |
| 2021-09-30 | $487.00K 10-Q · filed 2022-11-14 | $1.39M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $745.00K 10-Q · filed 2022-08-12 | $963.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $57.00K 10-Q · filed 2022-05-12 | $290.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $288.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $64.00K 10-Q · filed 2021-11-05 | $208.00K derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-06-30 | $72.00K 10-Q · filed 2021-08-10 | $166.00K derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-03-31 | $55.00K 10-Q · filed 2021-05-06 | $161.00K derived: sum of 4 quarters · filed 2022-03-30 |
| 2019-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $126.00K 10-K · filed 2022-03-30 |
| 2019-09-30 | $22.00K 10-Q · filed 2020-11-06 | $109.00K derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | $67.00K 10-Q · filed 2020-08-07 | $146.00K derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-03-31 | $20.00K 10-Q · filed 2020-05-08 | $170.00K derived: sum of 4 quarters · filed 2021-03-30 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $231.00K 10-K · filed 2021-03-30 |
| 2018-09-30 | $59.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $91.00K 10-Q · filed 2019-08-13 | |
| 2018-03-31 | $81.00K 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $66.00K 10-K · filed 2020-03-09 |